Noriko Uchiyama Selected Research

Noriko Uchiyama Research Topics

8	Neoplasms (Cancer) 08/2020 - 03/2012
4	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 03/2009
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2017
2	Cognitive Dysfunction 01/2017 - 01/2017
1	Prostatic Neoplasms (Prostate Cancer) 10/2017
1	Phototoxic Dermatitis (Phototoxicity) 01/2017
1	Schizophrenia (Dementia Praecox) 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 03/2012
1	Leukemia 03/2012
1	Amyloid Plaque 12/2011
1	Tauopathies 11/2009
1	Disease Progression 11/2009
1	Neuralgia (Stump Neuralgia) 09/2008
1	Bone Resorption 09/2008

2	hypusineIBA 08/2020 - 01/2020
2	EnzymesIBA 08/2020 - 01/2017
2	Histones (Histone)IBA 10/2017 - 01/2017
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2017 - 01/2017
2	Cyclic NucleotidesIBA 01/2017 - 01/2017
2	PyrazinesIBA 01/2017 - 01/2017
2	Type 2 Cyclic Nucleotide PhosphodiesterasesIBA 01/2017 - 01/2017
2	4- ((9- cyclopentyl- 7,7- difluoro- 5- methyl- 6- oxo- 6,7,8,9- tetrahydro- 5H- pyrimido(4,5- b)(1,4)diazepin- 2- yl)amino)- 2- fluoro- 5- methoxy- N- (1- methylpiperidin- 4- yl)benzamideIBA 06/2013 - 03/2012
2	Glycogen Synthase Kinase 3IBA 12/2011 - 11/2009
2	Glycogen Synthase (Synthase I)IBA 12/2011 - 03/2009
1	hexosaminidase CIBA 01/2021
1	deoxyhypusine synthaseIBA 08/2020
1	Eukaryotic Translation Initiation Factor 5AIBA 08/2020
1	Oncogene Proteins (Oncogene Protein)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	MicroRNAs (MicroRNA)IBA 10/2017
1	aristeromycinIBA 10/2017
1	3-deazaneplanocinIBA 10/2017
1	AndrogensIBA 10/2017
1	HomocysteineIBA 10/2017
1	Hormones (Hormone)IBA 10/2017
1	pyrimidineIBA 01/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2012
1	OxadiazolesIBA 12/2011
1	Amyloid (Amyloid Fibrils)IBA 12/2011
1	benzofuranIBA 12/2011
1	Glycogen Synthase KinasesIBA 10/2009
1	tau Proteins (tau Protein)IBA 03/2009
1	cathepsin SIBA 09/2008
1	Cathepsin KIBA 09/2008

5	Therapeutics 01/2018 - 03/2012
2	Oral Administration 03/2012 - 09/2008